Literature DB >> 11341140

Thrombolytics in elderly patients: a triumph of hope over experience?

D R Thiemann1, S P Schulman.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11341140      PMCID： PMC81021     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Thrombolytic therapy for patients with myocardial infarction who are older than 75 years. Do the risks outweigh the benefits?

Authors:  J Z Ayanian; E Braunwald
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

2.  Thrombolytic therapy in the elderly.

Authors:  H D White
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

3.  Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service.

Authors:  E Guadagnoli; M B Landrum; E A Peterson; M T Gahart; T J Ryan; B J McNeil
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

4.  Thrombolytic therapy in older patients.

Authors:  A K Berger; M J Radford; Y Wang; H M Krumholz
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

5.  Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995).

Authors:  R J Goldberg; D McCormick; J H Gurwitz; J Yarzebski; D Lessard; J M Gore
Journal:  Am J Cardiol       Date:  1998-12-01       Impact factor: 2.778

6.  The association between hospital volume and survival after acute myocardial infarction in elderly patients.

Authors:  D R Thiemann; J Coresh; W J Oetgen; N R Powe
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

7.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

8.  Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction.

Authors:  J M Boucher; N Racine; T H Thanh; E Rahme; J Brophy; J LeLorier; P Théroux
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

9.  Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).

Authors:  A P Maggioni; A Maseri; C Fresco; M G Franzosi; F Mauri; E Santoro; G Tognoni
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
  10 in total
  2 in total

1.  Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  Anthony Kerigan
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

2.  Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates.

Authors:  Karen L Kaplan; Patricia Fitzpatrick; Christopher Cox; Nicolas W Shammas; Victor J Marder
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.